Skip to main content
. 2015 Jun 29;10(6):e0130989. doi: 10.1371/journal.pone.0130989

Table 1. Patient characteristics and complementary data.

Overall population (n = 743) Survivors (n = 597) Deaths (n = 146) p *
Sex (male) (%) 62.2 62.5 61.0 0.734
Age (years) 67 ± 15 67 ± 15 67 ± 13 0.782
Location prior to admission (%) <0.001
Emergency room 27.1 29.3 17.8
General ward 50.4 47.1 64.4
ICU 1 13.1 12.7 14.4
Operating room 6.0 7.5 0.0
Other centre 3.4 3.4 3.4
Type of admission (%) <0.001
Medical, non-urgent 10.6 9.2 16.4
Medical, urgent 78.1 77.1 82.2
Surgical 11.3 13.7 1.4
Reason for admission (%) <0.001
Sepsis 21.9 20.1 29.5
Respiratory failure 34.2 31.7 44.5
Cardiovascular 11.6 12.7 6.8
Gastrointestinal 9.8 10.4 7.5
Neurologic 4.8 4.9 4.8
Monitoring 14.0 16.2 4.8
Other 3.7 4.0 2.1
Do-not resuscitate orders (%) 19.7 13.4 45.2 <0.001
ECOG (%) <0.001
0 and 1 28.7 32.8 11.6
2 42.9 44.1 38.4
3 and 4 28.4 23.1 50.0
Infection at admission (%) <0.001
Acquired in the community 18.2 20.8 7.5
Health-care related 49.5 42.2 79.5
Previous length of stay (days) 3 (0–8) 2 (0–7) 6 (1–12) 0.059
Metastatic cancer (%) 25.6 19.6 49.5 <0.001
Immunosuppressive therapy (%) 44.4 38.5 68.5 <0.001
Cirrhosis (%) 9.2 7.0 17.8 <0.001
COPD 2 (%) 19.5 21.1 13.0 0.027
Hypertension (%) 51.5 53.1 45.2 0.087
Systolic BP 3 (mmHg) 117 ± 27 118 ± 27 115 ± 25 0.209
Heart rate (lpm) 93 ± 21 91 ± 20 101 ± 21 <0.001
Supplemental oxygen support (%) <0.001
None 36.0 40.2 19.2
Oxygen support without NIV 4 38.4 38.7 37.0
NIV 4 25.6 21.1 43.8
Glasgow comma scale ≤12 (%) 8.5 7.4 13.0 0.028
pCO2 (mmHg) 41 ± 12 42 ± 12 38 ± 12 <0.001
Lactate ≥3 mmol/L (%) 11.7 9.2 21.9 <0.001
Haemoglobin (g/dL) 10.8 ± 2.3 10.9 ± 2.4 10.3 ± 1.9 0.005
Leukocytes (/mcL) 10.7 ± 7.0 10.5 ± 6.6 11.7 ± 8.2 0.103
Platelets (/mcL) 222 ± 148 229 ± 143 194 ± 164 0.018
Pro-thrombin time (%) 79.1 ± 42.0 81.0 ± 45.1 71.5 ± 24.8 0.017
C-reactive protein (mg/dL) 12.4 ± 11.3 12.0 ± 11.3 14.1 ± 11.5 0.056
Creatinine (mg/dL) 1.4 ± 1.1 1.4 ± 1.1 1.6 ± 1.2 0.182
Urea (g/L) 0.60 ± 0.42 0.57 ± 0.39 0.75 ± 0.47 <0.001
RIFLE score (%) 0.026
Risk 10.6 9.9 13.7
Injury 5.8 5.4 7.5
Failure 4.3 3.4 8.2
Loss 0.3 0.2 0.7
ESRD 5 2.2 2.0 2.7
Albumin (g/dL) 2.8 ± 0.8 2.8 ± 0.8 2.5 ± 0.7 <0.001
Bilirubin (mg/dL) 2.2 ± 5.0 1.8 ± 4.1 3.9 ± 6.9 0.001
Lowest SPB 6 , 24 hours (mmHg) 99 ± 19 100 ± 19 93 ± 19 <0.001
Vasoactive drugs, 24 hours (%) 17.6 16.2 23.3 0.045
Blood supplements, 24 hours (%) 34.7 31.5 47.9 <0.001
Urine output, 24 hours (mL) 1771 (1135–2690) 1850 (1179–2700) 1585 (894–2577) 0.017
SAPS II score (expected mortality rate) 33.1 ± 12.9 (19.2%) 30.6 ± 11.6 (15.5%) 43.6 ± 12.6 (34.3%) <0.001
SAPS 3 score (expected mortality rate) 60.3 ± 14.0 (38.2%) 57.5 ± 13.3 (33.6%) 71.7 ± 10.8 (57.5%) <0.001
Location at discharge (%) <0.001
General ward 77.4 85.8 43.6
ICU 1 10.0 6.0 26.3
Operating room 3.7 3.9 2.7
Other centre 1.8 2.3 0.0
Home 1.7 2.0 0.0
Death (in ImCU 7 ) 5.4 0.0 27.4

* All the remaining variables including diabetes, dyslipidemia, heart failure, previous coronary heart disease, heart arrhythmia, neurologic illness, body mass index, temperature, pH, sodium, potassium, magnesium and GPT were not statistically significant. Some variables described as continuous were also studied as polychotomous and dichotomous ones.

1 ICU: Intensive Care Unit.

2 COPD: Chronic Obstructive Pulmonary Disease.

3 BP: Blood Pressure.

4 NIV: Non-invasive Ventilation.

5 ESRD: End-Stage Renal Disease.

6 SBP: Systolic Blood Pressure.

7 ImCU: Intermediate Care Unit.